Magazine Article | October 30, 2014

Cannabis-Based Pharmaceuticals: The Next Frontier?

Source: Life Science Leader
Cliff Mintz

By Cliff Mintz

The current U.S. legal/regulatory landscape has given rise to two distinct types of companies that are attempting to commercialize cannabis products. The first of these is commonly referred to as medical marijuana companies, or as Steven Schultz, VP of investor relations at GW Pharma suggested, “nutraceutical or herbal remedy companies that promote the medicinal properties of cannabis.”